N-benzyl-N-[2-[6-[[(Z)-but-2-en-2-yl]-ethylamino]-3-pyridinyl]-2-hydroxyethyl]-2-chloroacetamide
C22H28ClN3O2 — CID 143143486
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-benzyl-N-[2-[6-[[(Z)-but-2-en-2-yl]-ethylamino]-3-pyridinyl]-2-hydroxyethyl]-2-chloroacetamide
N-benzyl-N-[2-[6-[[(Z)-but-2-en-2-yl]-ethylamino]-3-pyridinyl]-2-hydroxyethyl]-2-chloroacetamide (PubChem CID 143143486) has the molecular formula C22H28ClN3O2 and a molecular weight of 401.94 g/mol. Its IUPAC name is N-benzyl-N-[2-[6-[[(Z)-but-2-en-2-yl]-ethylamino]-3-pyridinyl]-2-hydroxyethyl]-2-chloroacetamide.
Molecular Properties
| Compound Name | N-benzyl-N-[2-[6-[[(Z)-but-2-en-2-yl]-ethylamino]-3-pyridinyl]-2-hydroxyethyl]-2-chloroacetamide |
|---|---|
| PubChem CID | 143143486 |
| Molecular Formula | C22H28ClN3O2 |
| Molecular Weight | 401.94 g/mol |
| Exact Mass | 401.19 |
| IUPAC Name | N-benzyl-N-[2-[6-[[(Z)-but-2-en-2-yl]-ethylamino]-3-pyridinyl]-2-hydroxyethyl]-2-chloroacetamide |
| SMILES | C/C=C(/C)N(CC)c1ccc(C(O)CN(Cc2ccccc2)C(=O)CCl)cn1 |
| InChI | InChI=1S/C22H28ClN3O2/c1-4-17(3)26(5-2)21-12-11-19(14-24-21)20(27)16-25(22(28)13-23)15-18-9-7-6-8-10-18/h4,6-12,14,20,27H,5,13,15-16H2,1-3H3/b17-4- |
| InChIKey | MGIDAFFWJHODSZ-INGKJJEOSA-N |
| XLogP | 4.13 |
| TPSA | 56.67 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 9 |
| Heavy Atoms | 28 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 401.94 |
| LogP ≤ 5 | 4.13 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 4 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'alkyl_halide', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 143143486 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.